LRMR:NASDAQ
Larimar Therapeutics Inc
$3.83
arrow_upward
+1.06%(+0.040) 1D
$3.87
arrow_upward
+1.04% (+0.040)bedtimeAfter hours
Closed: Sep 21, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LRMR...
Open
$3.84
High
$3.88
Low
$3.78
Mkt. cap
397.87M
Avg. vol.
1.06M
Volume
577.96K
52-wk high
$6.42
52-wk low
$2.72
EPS
-$1.99
Beta
0.74
Shares outstanding
103.88M
No. of employees
71
Open
$3.84
High
$3.88
Low
$3.78
Mkt. cap
397.87M
Avg. vol.
1.06M
Volume
577.96K
52-wk high
$6.42
52-wk low
$2.72
EPS
-$1.99
Beta
0.74
Shares outstanding
103.88M
No. of employees
71
News stories
From web sources and news partners
CarePlus VietNam
·
1 week ago
Larimar Therapeutics (LRMR) Q2 2026 Earnings: Narrower Loss Beats Consensus by 22.84% as Stock Gains 6.4%
CarePlus VietNam
·
3 weeks ago
Larimar (LRMR) Earnings Snapshot: EPS Prints Above Forecast at the Close; Share Move: The Market Price Advances 2.72% - Revenue Miss Report
CarePlus VietNam
·
1 month ago
LRMR Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.30 Signals Continued Clinical Progress - Profit Recovery Report
CarePlus VietNam
·
2 months ago
LRMR Q1 2026 Earnings: Net Loss Narrower Than Expected as Cost Discipline Continues - Guidance Upgrade Report
About Larimar Therapeutics Inc
CEO-
Employees71
Founded2005
HeadquartersBala Cynwyd, Pennsylvania, United States
SectorBiotechnology
Websitelarimartx.com